Grass pollen immunotherapy: Symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 107 (6) , 971-976
- https://doi.org/10.1067/mai.2001.115483
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trialJournal of Allergy and Clinical Immunology, 2001
- Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffectedJournal of Allergy and Clinical Immunology, 2000
- The Th1/Th2 paradigm and allergic disordersAllergy, 1998
- Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: Effect of topical corticosteroids☆☆☆★★★Journal of Allergy and Clinical Immunology, 1998
- Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.The Journal of Experimental Medicine, 1996
- The phenotype of human eosinophils, basophils, and mast cellsJournal of Allergy and Clinical Immunology, 1994
- Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cellsJournal of Allergy and Clinical Immunology, 1992
- Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavityJournal of Allergy and Clinical Immunology, 1991
- Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitroJournal of Allergy and Clinical Immunology, 1990
- IgG Subclass Antibody Response in Grass Pollen‐Allergic Patients Undergoing Specific ImmunotherapyAllergy, 1984